article thumbnail

Addressing Specialty Pharmacy Adherence Challenges Head On

Omnicell

Sarah Kester, PharmD Pharmaceutical Program Manager, Omnicell Specialty Pharmacy Services Medication non-adherence is a crippling problem in healthcare today, causing unnecessary hospitalizations and escalating costs. 2 Specialty pharmacy is a hotbed for adherence issues.

article thumbnail

Omnicell Announces Acquisition of 340B Link Business

Omnicell

Ngo EVP, Marketing, Strategy & Business Development, Omnicell For more than 25 years, the 340B Drug Pricing Program has provided financial assistance to hospitals and other healthcare facilities serving vulnerable communities to manage rising prescription drug costs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASHP Midyear 2022: Partnering for Optimized Pharmacy Outcomes

Omnicell

As healthcare navigates new and growing challenges post COVID-19 – including labor challenges, supply chain challenges, and disconnected systems – pharmacy leaders need innovative solutions that deliver optimized business and clinical outcomes for medication management. And Omnicell is more than a vendor.

article thumbnail

NASP 2022 Reveals a Pharmacy Landscape Shifting to Specialty

Omnicell

Kristen Dowd Director, Pharmacy Management Services, Omnicell If the 2022 NASP (National Association of Specialty Pharmacy) Annual Meeting and Expo is any indication, we are approaching a time when specialty pharmacy simply becomes pharmacy – when complex, high-touch biologics become nearly as ubiquitous as their broad-spectrum counterparts.

article thumbnail

Omnicell Unveils Specialty Pharmacy Services in Summer 2022 Release

Omnicell

Carmine DeNardo VP and General Manager, Specialty Pharmacy Services, Omnicell Despite the widespread adoption of electronic health records, pharmacy management systems, and other digital technologies, managing patients and medications across the continuum of care remains a significant challenge.

article thumbnail

In the Face of Resistance, 340B Coalition Summer Conference Proves Program’s Worth

Omnicell

During an Omnicell-hosted View from Capitol Hill Luncheon and Panel Discussion , Cathy White, 340B Pharmacy Financial Analyst at Cone Health, explained how manufacturer restrictions have impacted her organization. Omnicell can be a valued partner in this effort.

article thumbnail

17 Different Contract Pharmacy Policies and Counting

Omnicell

They have placed various restrictions on access to 340B discounts in the retail and specialty pharmacy setting. However, it has been stymied by federal district courts that have issued mixed decisions on the legality of the contract pharmacy program. In its recent budget request to Congress, HRSA also calls on lawmakers to act.